Fuss Brands Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024	Mar. 18	CI
Fuss Brands Corp. Reports Earnings Results for the Full Year Ended October 31, 2023	Feb. 05	CI
Fuss Brands Corp. Announces Resignation of Issamar Ginzberg as Chief Executive Officer	Jan. 11	CI
Fuss Brands Corp. Announces Board Changes	Jan. 11	CI
Fuss Brands Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	23-09-05	CI
Fuss Brands Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	23-06-12	CI
Fuss Brands Corp. Reports Earnings Results for the First Quarter Ended January 31, 2023	23-03-09	CI
Fuss Brands Corp. Reports Earnings Results for the Full Year Ended October 31, 2022	23-01-27	CI
Fuss Brands Corp. Receives Purchase Order from Roomwagon, LLC	23-01-27	CI
Fuss Brands Corp. Auditor Raises 'Going Concern' Doubt	23-01-26	CI
Fuss Brands Corp. announced that it has received $0.078 million in funding	23-01-17	CI
Fuss Brands Corp. Signs Licensing Agreement with Anyvention Ltd. to Acquire Intellectual Property Rights	22-11-04	CI
Fuss Brands Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	22-09-08	CI
China Botanic Pharmaceuticals Inc. has Changed its Name to Fuss Brands Corp	22-07-22	CI
China Botanic Pharmaceutical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022	22-06-08	CI

More news

Press releases China Botanic Pharmaceutical Inc.

FUSS BRANDS CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT OF OPERATIONS (form 10-K)	23-01-27	AQ
FUSS BRANDS CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-01-27	AQ
FUSS BRANDS CORP. Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K/A)	23-01-04	AQ
FUSS BRANDS CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22-12-05	AQ
Fuss Brands Corp. Signs Licensing Agreement with Anyvention Ltd. to Acquire Intellectual Property Rights	22-11-04	GL

More press releases

Fuss Brands Corp. is a shell company. The Company intends to explore and identify business opportunities within the United States, including an acquisition of an operating entity through a reverse merger, asset purchase, or similar transaction. The Company has no operations and has not generated any revenue.

Sector

More about the company

China Botanic Pharmaceutical Inc. Stock Other OTC

Equities

CBPI

US16890Y1047

Chart China Botanic Pharmaceutical Inc.

Latest news about China Botanic Pharmaceutical Inc.

Press releases China Botanic Pharmaceutical Inc.

Company Profile